The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
21 12 2020
Historique:
received: 22 07 2019
accepted: 16 11 2020
entrez: 22 12 2020
pubmed: 23 12 2020
medline: 16 1 2021
Statut: epublish

Résumé

Wnt/β-catenin signaling is crucial for intestinal carcinogenesis and the maintenance of intestinal cancer stem cells. Here we identify the histone methyltransferase Mll1 as a regulator of Wnt-driven intestinal cancer. Mll1 is highly expressed in Lgr5

Identifiants

pubmed: 33349639
doi: 10.1038/s41467-020-20222-z
pii: 10.1038/s41467-020-20222-z
pmc: PMC7752919
doi:

Substances chimiques

Histones 0
KMT2A protein, human 0
LGR5 protein, human 0
Receptors, G-Protein-Coupled 0
beta Catenin 0
Myeloid-Lymphoid Leukemia Protein 149025-06-9
Histone-Lysine N-Methyltransferase EC 2.1.1.43
Polycomb Repressive Complex 2 EC 2.1.1.43
Lysine K3Z4F929H6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6422

Références

Cell. 1996 Oct 18;87(2):159-70
pubmed: 8861899
Cell. 1996 Aug 9;86(3):391-9
pubmed: 8756721
Cell. 2012 Jul 6;150(1):12-27
pubmed: 22770212
Dev Biol. 2018 Jan 15;433(2):324-343
pubmed: 29108672
Genome Biol. 2004;5(10):R80
pubmed: 15461798
Gastroenterology. 2006 Jul;131(1):117-29
pubmed: 16831596
Science. 2001 Dec 7;294(5549):2155-8
pubmed: 11739954
Cancer Res. 2016 Feb 15;76(4):891-901
pubmed: 26645562
N Engl J Med. 2016 Sep 22;375(12):1109-12
pubmed: 27653561
Gastroenterology. 2016 Oct;151(4):684-697.e12
pubmed: 27342214
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Diabetes. 2003 Mar;52(3):588-95
pubmed: 12606497
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Mol Cell. 2016 Jul 21;63(2):318-328
pubmed: 27447986
Oncogene. 2016 Feb 4;35(5):549-57
pubmed: 25915847
Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3472-7
pubmed: 24550486
Cell. 2009 Mar 6;136(5):903-12
pubmed: 19269367
Science. 1998 Apr 24;280(5363):596-9
pubmed: 9554852
Nature. 2008 Apr 3;452(7187):650-3
pubmed: 18385740
Cancer Res. 2014 Feb 1;74(3):775-86
pubmed: 24247718
Science. 2016 Jun 3;352(6290):aad9780
pubmed: 27257261
Cell Stem Cell. 2016 Jan 7;18(1):91-103
pubmed: 26526724
Genome Biol. 2008;9(2):R26
pubmed: 18248669
Cell. 2000 Oct 13;103(2):311-20
pubmed: 11057903
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3665-70
pubmed: 21307310
Nat Rev Genet. 2006 May;7(5):349-59
pubmed: 16619050
Nature. 2012 Dec 6;492(7427):108-12
pubmed: 23051747
Biostatistics. 2003 Apr;4(2):249-64
pubmed: 12925520
Bioinformatics. 2004 Feb 12;20(3):307-15
pubmed: 14960456
Nature. 2009 Jan 29;457(7229):608-11
pubmed: 19092804
Nature. 2017 Mar 29;543(7647):676-680
pubmed: 28358093
Nat Methods. 2013 Nov;10(11):1096-8
pubmed: 24056875
EMBO J. 1997 Jul 1;16(13):3797-804
pubmed: 9233789
Mol Cell Biol. 2009 Nov;29(22):6074-85
pubmed: 19703992
Gastroenterology. 2011 Apr;140(4):1219-1229.e1-2
pubmed: 21262227
Cell Rep. 2019 Jan 8;26(2):415-428.e5
pubmed: 30625324
Nat Genet. 2012 Jan 27;44(2):127-30
pubmed: 22281773
J Cell Biol. 2004 Jul 5;166(1):37-47
pubmed: 15240568
Science. 1997 Mar 21;275(5307):1787-90
pubmed: 9065402
Cell Rep. 2013 Dec 26;5(6):1704-13
pubmed: 24332856
Nat Cell Biol. 2010 May;12(5):468-76
pubmed: 20418870
Nat Rev Cancer. 2008 May;8(5):387-98
pubmed: 18432252
Cell. 2013 Jul 18;154(2):274-84
pubmed: 23870119
Cell Stem Cell. 2011 May 6;8(5):511-24
pubmed: 21419747
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5
pubmed: 23193258
Cell. 2016 Jun 2;165(6):1389-1400
pubmed: 27212235
EMBO J. 2012 Jun 12;31(14):3079-91
pubmed: 22692129
EMBO J. 2017 Apr 3;36(7):869-885
pubmed: 28077488
Nat Genet. 1998 Aug;19(4):379-83
pubmed: 9697701
Cell. 2018 Apr 5;173(2):400-416.e11
pubmed: 29625055
Cell. 2012 Jun 8;149(6):1192-205
pubmed: 22682243
Genes Dev. 2004 Jun 15;18(12):1385-90
pubmed: 15198980
Nature. 2007 Oct 25;449(7165):1003-7
pubmed: 17934449
Nat Genet. 1999 Jan;21(1):70-1
pubmed: 9916792
Mol Cell Biol. 2002 Feb;22(4):1184-93
pubmed: 11809809
Cell Mol Gastroenterol Hepatol. 2016 Mar;2(2):189-209
pubmed: 27066525
Gastroenterology. 2009 Oct;137(4):1333-45.e1-3
pubmed: 19549527
Development. 2005 Mar;132(6):1443-51
pubmed: 15716339
Genesis. 2010 Aug;48(8):512-20
pubmed: 20506501
Nature. 2005 Jun 16;435(7044):964-8
pubmed: 15959516
Nat Genet. 2017 Nov;49(11):1624-1632
pubmed: 28945253
EMBO J. 1999 Nov 1;18(21):5931-42
pubmed: 10545105
EMBO Rep. 2004 Apr;5(4):373-7
pubmed: 15031712
Cell Mol Gastroenterol Hepatol. 2016 Oct 21;3(1):51-71
pubmed: 28174757
Nature. 1996 Aug 15;382(6592):638-42
pubmed: 8757136
Cancer Res. 2004 Oct 15;64(20):7220-5
pubmed: 15492237
Nature. 2017 Nov 16;551(7680):333-339
pubmed: 29144463
Cancer Sci. 2010 Jul;101(7):1731-7
pubmed: 20384634
EMBO J. 2013 Jul 17;32(14):1977-89
pubmed: 23736260
Gastroenterology. 2007 Feb;132(2):628-32
pubmed: 17320548
Cell Mol Life Sci. 2002 Jan;59(1):156-70
pubmed: 11846026
Nat Cell Biol. 2014 Jul;16(7):695-707
pubmed: 24952462
Development. 2012 Feb;139(3):488-97
pubmed: 22190634
Mol Cell Biol. 2012 May;32(10):1918-27
pubmed: 22393260
Blood. 2013 Sep 19;122(12):2039-46
pubmed: 23908472

Auteurs

Johanna Grinat (J)

Cancer Research Program, Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Society, 13125, Berlin, Germany.

Julian Heuberger (J)

Cancer Research Program, Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Society, 13125, Berlin, Germany. julian.heuberger@charite.de.
Division of Gastroenterology and Hepatology, Medical Department, Charité University Medicine, 13353, Berlin, Germany. julian.heuberger@charite.de.

Ramon Oliveira Vidal (RO)

Laboratory of Functional Genomics, Nutrigenomics and Systems Biology, Scientific Genomics Platforms, Max Delbrück Center for Molecular Medicine (BIMSB/BIH), 13092, Berlin, Germany.

Neha Goveas (N)

Biotechnology Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Dresden, Germany.

Frauke Kosel (F)

Cancer Research Program, Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Society, 13125, Berlin, Germany.

Antoni Berenguer-Llergo (A)

Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Andrea Kranz (A)

Biotechnology Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Dresden, Germany.

Annika Wulf-Goldenberg (A)

Experimental Pharmacology & Oncology (EPO), 13125, Berlin, Germany.

Diana Behrens (D)

Experimental Pharmacology & Oncology (EPO), 13125, Berlin, Germany.

Bálint Melcher (B)

Institute for Pathology, Klinikum Bayreuth, 95445, Bayreuth, Germany.

Sascha Sauer (S)

Laboratory of Functional Genomics, Nutrigenomics and Systems Biology, Scientific Genomics Platforms, Max Delbrück Center for Molecular Medicine (BIMSB/BIH), 13092, Berlin, Germany.

Michael Vieth (M)

Institute for Pathology, Klinikum Bayreuth, 95445, Bayreuth, Germany.

Eduard Batlle (E)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.

A Francis Stewart (AF)

Biotechnology Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Dresden, Germany.

Walter Birchmeier (W)

Cancer Research Program, Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Society, 13125, Berlin, Germany. wbirch@mdc-berlin.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH